HIV and tumor molecular characterization project (htmcp)
Ended Awarded Last action
- Contract number
- 75N91018F00065
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,496,274
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $1,496,274.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,496,274 |
About this award
This is a $1,496,274.00 cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract supports the HIV and Tumor Molecular Characterization Project (HTMCP), which is a biomedical research effort focused on cancer and HIV. The contract has a period of performance ending on September 30, 2022. Leidos Biomedical Research, which has previously supported various NIH research programs as a prime contractor and subcontractor, will provide services such as facilities operations, research and development, manufacturing, and clinical trials management for this project. The contract is not set aside for any specific business type.
Quick answers
Who was awarded contract 75N91018F00065?
75N91018F00065 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 24, 2018.
How much is contract 75N91018F00065 worth?
The government has obligated $1,496,274 on 75N91018F00065.
Is contract 75N91018F00065 an order under another contract?
Yes. 75N91018F00065 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract 75N91018F00065 competed?
The extent of competition for 75N91018F00065 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award